[1] Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M. Pain is common in Parkinson's disease[J]. Clin Neurol Neurosurg, 2011, 113:11-13. [2] Ford B. Pain in Parkinson's disease[J]. Mov Disord, 2010, 25 Suppl 1:98-103. [3] Buhmann C, Kassubek J, Jost WH. Management of pain in Parkinson's disease[J]. J Parkinsons Dis, 2020, 10(s1):37-48. [4] Buhmann C, Ip CW, Oehlwein C, Tönges L, Wolz M, Reichmann H, Kassubek J. Parkinson disease and pain:diagnostic and therapeutic approaches to a challenging non-motor symptom[J]. Fortschr Neurol Psychiatr, 2018, 86(S 01):48-58. [5] Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Dotto PD, Barone P, Vivo ED, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M. Pain as a nonmotor symptom of Parkinson disease[J]. Arch Neurol, 2008, 65:1191-1194. [6] Leroi I, Overshott R, Byrne EJ, Daniel E, Burns A. Randomized controlled trial of memantine in dementia associated with Parkinson's disease[J]. Mov Disord, 2009, 24:1217-1221. [7] Parkinson's Disease and Movement Disorders Group, Neurology Branch, Chinese Medical Association; Parkinson's Disease and Movement Disorders Specialty, Neurology Branch, Chinese Medical Doctor Association. Diagnostic criteria for Parkinson's disease in China (2016 edition)[J]. Zhonghua Shen Jing Ke Za Zhi, 2016, 49:268-271.[中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍专业. 中国帕金森病的诊断标准(2016版)[J]. 中华神经科杂志, 2016, 49:268-271.] [8] Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the mini-mental state examination by age and educational level[J]. JAMA, 1993, 269:2386-2391. [9] Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ. The MoCA:well-suited screen for cognitive impairment in Parkinson disease[J]. Neurology, 2010, 75:1717-1725. [10] Hamilton M. A rating scale for depression[J]. J Neurol Neurosurg Psychiatry, 1960, 23:56-62. [11] Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS):status and recommendations[J]. Mov Disord, 2003, 18:738-750. [12] Perez-Lloret S, Ciampi de Andrade D, Lyons KE, Rodríguez-Blázquez C, Chaudhuri KR, Deuschl G, Cruccu G, Sampaio C, Goetz CG, Schrag A, Martinez-Martin P, Stebbins G; Members of the MDS Committee on Rating Scales Development. Rating scales for pain in Parkinson's disease:critique and recommendations[J]. Mov Disord Clin Pract, 2016, 3:527-537. [13] Kinugawa K, Mano T, Sugie K. Neuronal dynamics of pain in Parkinson's disease[J]. Brain Sci, 2021, 11:1224. [14] Sun HH, Xiao PR. Analysis of risk factors on pain in PD patients[J]. Xian Dai Yi Xue Yu Jian Kang Yan Jiu (Dian Zi Ban), 2020, 4:109-110.[孙海华, 肖佩荣. PD患者疼痛的相关危险因素分析[J]. 现代医学与健康研究(电子版), 2020, 4:109-110.] [15] DeLong MR. Primate models of movement disorders of basal ganglia origin[J]. Trends Neurosci, 1990, 13:281-285. [16] Silverdale MA, Kobylecki C, Kass-Iliyya L, Martinez-Martin P, Lawton M, Cotterill S, Chaudhuri KR, Morris H, Baig F, Williams N, Hubbard L, Hu MT, Grosset DG; UK Parkinson's Pain Study Collaboration. A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease[J]. Parkinsonism Relat Disord, 2018, 56:27-32. [17] Lin XJ, Yu N, Lin XG, Zhang YF, Chen Y, Zhang K, Wang XS, Liu WG. A clinical survey of pain in Parkinson's disease in Eastern China[J]. Int Psychogeriatr, 2016, 28:283-289. [18] Ehrt U, Larsen JP, Aarsland D. Pain and its relationship to depression in Parkinson disease[J]. Am J Geriatr Psychiatry, 2009, 17:269-275. [19] Ozturk EA, Gundogdu I, Kocer B, Comoglu S, Cakci A. Chronic pain in Parkinson's disease:frequency, characteristics, independent factors, and relationship with health-related quality of life[J]. J Back Musculoskelet Rehabil, 2016.[Epub ahead of print] [20] Grinberg LT, Rueb U, Alho AT, Heinsen H. Brainstem pathology and non-motor symptoms in PD[J]. J Neurol Sci, 2010, 289:81-88. [21] Neugebauer V. Amygdala pain mechanisms[J]. Handb Exp Pharmacol, 2015, 227:261-284. [22] Rukavina K, Leta V, Sportelli C, Buhidma Y, Duty S, Malcangio M, Ray Chaudhuri K. Pain in Parkinson's disease:new concepts in pathogenesis and treatment[J]. Curr Opin Neurol, 2019, 32:579-588. [23] Juri C, Rodriguez-Oroz M, Obeso JA. The pathophysiological basis of sensory disturbances in Parkinson's disease[J]. J Neurol Sci, 2010, 289:60-65. [24] Tong Q, Zhang L, Yuan Y, Jiang S, Zhang R, Xu Q, Ding J, Li D, Zhou X, Zhang K. Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms[J]. Parkinsonism Relat Disord, 2015, 21:882-887. [25] Rana AQ, Qureshi ARM, Shamli Oghli Y, Saqib Y, Mohammed B, Sarfraz Z, Rana R. Decreased sleep quality in Parkinson's patients is associated with higher anxiety and depression prevalence and severity, and correlates with pain intensity and quality[J]. Neurol Res, 2018, 40:696-701. [26] Djaldetti R, Yust-Katz S, Kolianov V, Melamed E, Dabby R. The effect of duloxetine on primary pain symptoms in Parkinson disease[J]. Clin Neuropharmacol, 2007, 30:201-205. [27] Defazio G, Antonini A, Tinazzi M, Gigante AF, Pietracupa S, Pellicciari R, Bloise M, Bacchin R, Marcante A, Fabbrini G, Berardelli A. Relationship between pain and motor and non-motor symptoms in Parkinson's disease[J]. Eur J Neurol, 2017, 24:974-980. [28] Vila-Chã N, Cavaco S, Mendes A, Gonçalves A, Moreira I, Fernandes J, Damásio J, Azevedo LF, Castro-Lopes J. Unveiling the relationship between central parkinsonian pain and motor symptoms in Parkinson's disease[J]. Eur J Pain, 2019, 23:1475-1485. [29] Fu YT, Mao CJ, Ma LJ, Zhang HJ, Wang Y, Li J, Huang JY, Liu JY, Liu CF. Pain correlates with sleep disturbances in Parkinson's disease patients[J]. Pain Pract, 2018, 18:29-37. |